309 related articles for article (PubMed ID: 30082842)
61. Immunoexpression of stem cell markers SOX-2, NANOG AND OCT4 in ameloblastoma.
Martins Balbinot K; Almeida Loureiro FJ; Chemelo GP; Alves Mesquita R; Cruz Ramos AMP; Ramos RTJ; da Costa da Silva AL; de Menezes SAF; da Silva Kataoka MS; Alves Junior SM; Viana Pinheiro JJ
PeerJ; 2023; 11():e14349. PubMed ID: 36655039
[TBL] [Abstract][Full Text] [Related]
62. TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.
Glaser ZA; Love HD; Guo S; Gellert L; Chang SS; Herrell SD; Barocas DA; Penson DF; Cookson MS; Clark PE
Urol Oncol; 2017 May; 35(5):286-293. PubMed ID: 28108243
[TBL] [Abstract][Full Text] [Related]
63. Comparison of Cellular Transforming Activity of OCT4, NANOG, and SOX2 in Immortalized Astrocytes.
Seo S; Jeon HY; Kim H
DNA Cell Biol; 2017 Nov; 36(11):1000-1009. PubMed ID: 28933914
[TBL] [Abstract][Full Text] [Related]
64. Isolation and characterization of renal cancer stem cells from patient-derived xenografts.
Hasmim M; Bruno S; Azzi S; Gallerne C; Michel JG; Chiabotto G; Lecoz V; Romei C; Spaggiari GM; Pezzolo A; Pistoia V; Angevin E; Gad S; Ferlicot S; Messai Y; Kieda C; Clay D; Sabatini F; Escudier B; Camussi G; Eid P; Azzarone B; Chouaib S
Oncotarget; 2016 Mar; 7(13):15507-24. PubMed ID: 26551931
[TBL] [Abstract][Full Text] [Related]
65. Galectin-9 expression as a poor prognostic factor in patients with renal cell carcinoma.
Jikuya R; Kishida T; Sakaguchi M; Yokose T; Yasui M; Hashizume A; Tatenuma T; Mizuno N; Muraoka K; Umemoto S; Kawai M; Yoshihara M; Nakamura Y; Miyagi Y; Sasada T
Cancer Immunol Immunother; 2020 Oct; 69(10):2041-2051. PubMed ID: 32424467
[TBL] [Abstract][Full Text] [Related]
66. Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma.
Seligson DB; Pantuck AJ; Liu X; Huang Y; Horvath S; Bui MH; Han KR; Correa AJ; Eeva M; Tze S; Belldegrun AS; Figlin RA
Clin Cancer Res; 2004 Apr; 10(8):2659-69. PubMed ID: 15102668
[TBL] [Abstract][Full Text] [Related]
67. Reduction of NANOG Mediates the Inhibitory Effect of Aspirin on Tumor Growth and Stemness in Colorectal Cancer.
Wang H; Liu B; Wang J; Li J; Gong Y; Li S; Wang C; Cui B; Xue X; Yang M; Fan W; Kang Z; Kamran M; Xu J; Tian P; Luo Y; Hou Z; Dong L; Ren Y; Li M; Wen Q; Cheng W; Xu L; Wang L; Liu Q
Cell Physiol Biochem; 2017; 44(3):1051-1063. PubMed ID: 29179207
[TBL] [Abstract][Full Text] [Related]
68. SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma.
Sherman-Samis M; Onallah H; Holth A; Reich R; Davidson B
Gynecol Oncol; 2019 Jun; 153(3):651-660. PubMed ID: 30904337
[TBL] [Abstract][Full Text] [Related]
69. The Coordinated Actions of TIM-3 on Cancer and Myeloid Cells in the Regulation of Tumorigenicity and Clinical Prognosis in Clear Cell Renal Cell Carcinomas.
Komohara Y; Morita T; Annan DA; Horlad H; Ohnishi K; Yamada S; Nakayama T; Kitada S; Suzu S; Kinoshita I; Dosaka-Akita H; Akashi K; Takeya M; Jinushi M
Cancer Immunol Res; 2015 Sep; 3(9):999-1007. PubMed ID: 25783986
[TBL] [Abstract][Full Text] [Related]
70. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma.
Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D
Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834
[TBL] [Abstract][Full Text] [Related]
71. Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma.
Visapää H; Bui M; Huang Y; Seligson D; Tsai H; Pantuck A; Figlin R; Rao JY; Belldegrun A; Horvath S; Palotie A
Urology; 2003 Apr; 61(4):845-50. PubMed ID: 12670587
[TBL] [Abstract][Full Text] [Related]
72. Comparative analysis of Oct4 in different histological subtypes of esophageal squamous cell carcinomas in different clinical conditions.
Vaiphei K; Sinha SK; Kochhar R
Asian Pac J Cancer Prev; 2014; 15(8):3519-24. PubMed ID: 24870750
[TBL] [Abstract][Full Text] [Related]
73. Ecto-5'-nucleotidase (CD73) is a biomarker for clear cell renal carcinoma stem-like cells.
Song L; Ye W; Cui Y; Lu J; Zhang Y; Ding N; Hu W; Pei H; Yue Z; Zhou G
Oncotarget; 2017 May; 8(19):31977-31992. PubMed ID: 28404888
[TBL] [Abstract][Full Text] [Related]
74. Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: a systematic study of 19 immunohistochemical markers in 42 cases.
Yu W; Wang Y; Jiang Y; Zhang W; Li Y
BMC Cancer; 2017 Apr; 17(1):293. PubMed ID: 28449664
[TBL] [Abstract][Full Text] [Related]
75. Low NR3C2 levels correlate with aggressive features and poor prognosis in non-distant metastatic clear-cell renal cell carcinoma.
Zhao Z; Zhang M; Duan X; Deng T; Qiu H; Zeng G
J Cell Physiol; 2018 Oct; 233(10):6825-6838. PubMed ID: 29693713
[TBL] [Abstract][Full Text] [Related]
76. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up.
Minardi D; Lucarini G; Filosa A; Milanese G; Zizzi A; Di Primio R; Montironi R; Muzzonigro G
Int J Immunopathol Pharmacol; 2008; 21(2):447-55. PubMed ID: 18547492
[TBL] [Abstract][Full Text] [Related]
77. The Prognostic Significance of Protein Expression of CASZ1 in Clear Cell Renal Cell Carcinoma.
Kim B; Jung M; Moon KC
Dis Markers; 2019; 2019():1342161. PubMed ID: 31481981
[TBL] [Abstract][Full Text] [Related]
78. PLIN3 is up-regulated and correlates with poor prognosis in clear cell renal cell carcinoma.
Wang K; Ruan H; Song Z; Cao Q; Bao L; Liu D; Xu T; Xiao H; Wang C; Cheng G; Tong J; Meng X; Yang H; Chen K; Zhang X
Urol Oncol; 2018 Jul; 36(7):343.e9-343.e19. PubMed ID: 29773494
[TBL] [Abstract][Full Text] [Related]
79. Lack of TMEM27 expression is associated with postoperative progression of clinically localized conventional renal cell carcinoma.
Javorhazy A; Farkas N; Beothe T; Pusztai C; Szanto A; Kovacs G
J Cancer Res Clin Oncol; 2016 Sep; 142(9):1947-53. PubMed ID: 27417314
[TBL] [Abstract][Full Text] [Related]
80. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
